Disclaimer: The analyst who wrote this piece owns shares of Strategy (MSTR).Strategy (MSTR) expects its convertible preferred ...

Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into ...

We recently published a list of the 12 Best E-Commerce Stocks to Buy According to Analysts. In this article, we are going to ...

K SEC filing received on January 31, 2025, that the company has been notified by The Nasdaq Stock Market, LLC about its failure to meet the minimum bid requirement for continued listing on the Nasdaq ...

Hotel101 Global—a unit of DoubleDragon, which is jointly owned by Philippine fast food giant Jollibee founder Tony Tan ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine ...

DoubleDragon Corp., the property venture of tycoons Edgar “Injap” Sia and Tony Tan Caktiong, has moved a step closer toward ...

DoubleDragon Corp., the property venture of tycoons Edgar Sia II and Tony Tan Caktiong, has moved a step closer toward ...

The 2022 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Zentalis, or following a bona fide period of non-employment, as an ...

The Nasdaq Composite is an often-cited stock market index — along with the S&P 500 and the Dow Jones Industrial Average — ...

DOUBLEDRAGON Corp.’s (DD) subsidiary, Hotel101 Global Pte. Ltd., is nearing its $2.3-billion (P130 billion) listing on the Nasdaq Stock Exchange in the United States after meeting all requirements.